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INTRODUCTION
o r l d w i d e , l o w e r s e g m e n t Wcaesarean section (LSCS) rate is increasing due to multiple reasons including breech presentation, previous caesarean section, placenta previa maternal anxiety, maternal own request 1, 2 and suspected fetal macrosomia. The caesarean section delivery is believed to be associated with maternal and neonatal complications as compared to 3 vaginal delivery. LSCS done before 39 weeks of gestational age is linked with 1 increased respiratory morbidity requiring admission to neonatal intensive care unit (NICU) and hence increasing cost on health services providers or on the parents. Caesarean is also associated with abnormal immune responses that lead to development of diseases like allergies, asthma, diabetes mellitus type 1 and 4 celiac disease.
Neonatal respiratory complications like respiratory distress syndrome (RDS) and transient tachypnea of newborn (TTN) are more common in infants delivered via LSCS as compared to those delivered vaginally. Studies have shown that about 50 % of neonates with RDS were due to the iatrogenic 5, 6 early term caesarean section. Apart from mode of delivery, the gestational age at the time of delivery also affects 5 the neonatal respiratory outcomes. Whereas, the risk is more in neonates born between 34 to 36 weeks of gestational age as compared to those 7 born at term. The risk of neonatal r e s p i r a t o r y c o m p l i c a t i o n s i s approximately 1.7 times when born 0 6 between 37+ to 37+ weeks as 0 compared to those between 38+ to 6 38+ weeks in whom the risk is about 2.4 times relatively more than those 0 5 born after 39+ weeks. Therefore, it is recommended for elective LSCS to be delayed up till 39 weeks of gestational age until seemed indispensable.
In order to reduce the respiratory complications, antenatal prophylactic corticosteroids are given as they accelerate the lung maturation and with neurotransmitter actions. The mechanism proposed in animal studies is possibly by the apoptosis and cell death therefore limiting the neuronal 10 growth and function. Due to this, the gestational age until which the steroids should be given is never agreed upon and their use beyond 34 weeks is still 7 controversial. The Royal College of Obstetricians and Gynaecologists (RCOG) recommends the antenatal c o r t i c o s t e r o i d s f o r a l l w o m e n undergoing planned elective caesarean 6 10 before 38+ weeks of gestational age. H o w e v e r, A m e r i c a n C o l l e g e o f Obstetricians and Gynecologists does n o t r e c o m m e n d a n t e n a t a l to 38+ weeks, admitted for elective L S C S u n d e r s p i n a l a n e s t h e s i a . gestational age of these patients was conrmed by the date of last menstrual period and in cases of unsure of dates, by the rst trimester dating scan.
Patients with uncomplicated gestational diabetes mellitus, pregnancy induced hypertension, anemia and asthma were included in both groups. Women with type 1 or 2 diabetes mellitus, chronic hypertension, preeclampsia, pre-labour rupture of membranes, multiple pregnancies, infections including tuberculosis, congenital anomalous fetus, intrauterine growth restriction Both the groups were followed at the time LSCS and assessed for the primary and secondary neonatal outcomes 
FINAL ANALYSIS RESULTS
A total of 320 patients were studied, and divided into groups "A" and "B". After scrutinizing these patients, they were randomly distributed in groups A and B and informed consent was taken.
The randomization was done on the basis of block randomization method. Group A was interventional or Dexa group and received one course of dexamethasone within 7 days of LSCS.
O n e c o u r s e o f d e x a m e t h a s o n e contained two doses of 12mg, each given intramuscularly to the pregnant woman, 12 hours apart. Group B was a non-interventional or control group that did not receive dexamethasone injection before LSCS.
For patients with gestational diabetes (GDM), blood sugar -random (BSR) was monitored along with the dose of dexamethasone and regular insulin was given according to sliding scale. All those pregnant patients who had received dexamethasone before 7 days at any time during pregnancy were also excluded from the study. The baseline characteristics of patients like age, parity, history of miscarriage were also noted.
All the patients were pursued in operation theatre, where elective LSCS was performed by the consultant gynecologist or senior resident and the delivered baby was received by the neonatologist. Primary outcomes included assessment of baby by Apgar scores at one and ve minutes, the needs for neonatal resuscitation, and admission of baby to NICU. The statistical analysis was performed with SPSS 23.0. Frequency and p e r c e n t a g e w a s c o m p u t e d f o r qualitative variables and chi-square test w a s a p p l i e d f o r a n a l y s i s . M e a n ± s t a n d a r d d e v i a t i o n w a s calculated for quantitative variables and then analyzed by Independent Samples t Test, keeping the level of signicance "p" value below 0.05. up to 1%. The main problem in these neonates is TTN that occurs because of delayed absorption of uid from the pulmonary alveoli and the steroids may promote the expression of sodium epithelial channels leading to clearance of uid, but this proposed mechanism 12, 13 has not been accepted universally.
The maximum benet is achieved when antenatal steroids are given 24 hours to 7 days before the delivery of fetus and this is obtained only in 12 to 25 % of 10 mothers. Caesarean section has been considered itself to be associated with neonatal respiratory morbidity; TTN more predominantly than RDS in term 2, 6 LSCS. A study conducted by Nabhan A, et al. a t E g y p t a b o u t a n t e n a t a l dexamethasone administration in caesarean deliveries between 34 to 37 weeks of gestational age showed no signicant reduction in the occurrence of RDS (p=0.699), TTN (p=0.612), NICU admission (p=0.535) and need for mechanical ventilation (p=0.509).
I n o u r s t u d y p r o p h y l a c t i c
The results are similar to that of our study, as we also didn't nd signicant differences in any of these neonatal p a r a m e t e r s . S i m i l a r l y, a n o t h e r randomized controlled trial conducted 12 by Porto A, et al. at Brazil showed no reduction in the incidence of RDS (p=0.54) and TTN (p=0.77) in both the steroid and control groups. There was no signicant difference amongst the two groups in need for ventilatory support, exogenous surfactant and type of ventilatory support. Rates of neonatal hypoglycemia was similar in both groups (p=0.31). These results are similar to our study but differ in inclusion criteria that it included all deliveries both caesarean and vaginal, between 34 to 36 w e e k s o f g e s t a t i o n a l a g e a n d b e t a m e t h a s o n e w a s g i v e n prophylactically. There was signicant reduction in need of phototherapy in neonatal jaundice in steroid group (p=0.01). However, that neonatal parameter was not included in our study.
In contrast to the current study, results of research conducted by Ismail KS, et 5 16 al. and Salem MN, et al. illustrated signicant reduction in incidence of neonatal respiratory morbidity and NICU admission in patients given a n t e n a t a l d e x a m e t h a s o n e . Figure  1 .
There were no signicant differences in the primary outcomes like neonatal weight at birth, Apgar score at 1 and 5 minutes, neonatal resuscitation and NICU admission in both groups, as shown in Table I Total neonates admitted to NICU in both groups were not statistically signicant. In group A, 18 neonates admitted in NICU, 4 with TTN and 2 with RDS,11 babies with GDM mothers and one baby with non-GDM mother had blood sugar monitoring.In group B, twelve neonates admitted, two with respiratory morbidity, seven babies with GDM mothers for blood sugar monitoring and three with secondary a p n e a r e v i v e d a f t e r n e o n a t a l resuscitation for observation.
given to pregnant women at term and should not be included in hospital protocols for all term caesarean deliveries GDM, 4 in steroid group. However, none of their neonate developed respiratory distress that was similar to our results.
There is only one study conducted in Pakistan that is retrospective with a small sample size. Their results are in contrast to our study and showed signicant reduction in development of TTN (p=0.005) and neonatal admission to NICU (p=0.044). However, length of hospital stay was insignicant 2 (p=0.18) that was similar to our study (p=0.546).
The TTN is a self-limiting condition, it usually resolves within 72 hours and few babies require intensive level treatment with supplemental oxygen. There is a difference between transitional delay and TTN. Transitional delay is the shorter periods of tachypnea in babies after birth and is self-resolving within a few hours, length varying between 2 to 13 6 hours. TTN may be the severe expression of the disease. Therefore, further research should be carried out to investigate the above conditions.
STRENGTH AND LIMITATIONS
The main strength of this research is that it is a prospective randomized control trial with a reasonable sample size. In the previous studies, medical disorders were excluded, however, in this study, chronic medical diseases were excluded but equal number of patients with gestational hypertension and GDM were included in both groups.
The main limitation of this study is that the stratication of gestational ages was not done and neonatal outcomes were not compared at different gestational age after 37 weeks. Blinding of participants and professionals was not done.
CONCLUSION
Dexamethasone administration in term LSCS after 37 weeks of gestational age has no signicant effects on reducing the incidence of RDS, TTN and neonatal admission. GDM alone is not a risk factor for RDS development. Due to long-term adverse effects of steroids in neonates, they should be judiciously
